Articles de revues sur le sujet « Risk variants »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Risk variants ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Shah, Shrijal S., Herbert Lannon, Leny Dias, et al. "APOL1 Kidney Risk Variants Induce Cell Death via Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore." Journal of the American Society of Nephrology 30, no. 12 (2019): 2355–68. http://dx.doi.org/10.1681/asn.2019020114.
Texte intégralBayley, Jean Pierre, Birke Bausch, Johannes Adriaan Rijken, et al. "Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma–paraganglioma." Journal of Medical Genetics 57, no. 2 (2019): 96–103. http://dx.doi.org/10.1136/jmedgenet-2019-106214.
Texte intégralHan, Shengtong. "Bayesian Rare Variant Analysis Identifies Novel Schizophrenia Putative Risk Genes." Journal of Personalized Medicine 14, no. 8 (2024): 822. http://dx.doi.org/10.3390/jpm14080822.
Texte intégralPark, Jihye, Soo Youn Lee, Su Youn Baik, et al. "Gene-Wise Burden of Coding Variants Correlates to Noncoding Pharmacogenetic Risk Variants." International Journal of Molecular Sciences 21, no. 9 (2020): 3091. http://dx.doi.org/10.3390/ijms21093091.
Texte intégralBarbirou, Mouadh, Amanda A. Miller, Amel Mezlini, Balkiss Bouhaouala-Zahar, and Peter J. Tonellato. "Variant Characterization of a Representative Large Pedigree Suggests “Variant Risk Clusters” Convey Varying Predisposition of Risk to Lynch Syndrome." Cancers 15, no. 16 (2023): 4074. http://dx.doi.org/10.3390/cancers15164074.
Texte intégralCannon-Albright, Lisa Anne, Craig Carl Teerlink, Jeff Stevens, et al. "A Rare Variant in ERF (rs144812092) Predisposes to Prostate and Bladder Cancers in an Extended Pedigree." Cancers 13, no. 10 (2021): 2399. http://dx.doi.org/10.3390/cancers13102399.
Texte intégralBychkovsky, Brittany L., Nihat B. Agaoglu, Carolyn Horton, et al. "Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes." JAMA Network Open 8, no. 1 (2025): e2451361. https://doi.org/10.1001/jamanetworkopen.2024.51361.
Texte intégralCornelis, Stéphanie S., and Frans P. M. Cremers. "Improving personalised genetic counselling for ABCA4 -associated retinopathy: Updated recurrence risk estimates." Medizinische Genetik 37, no. 1 (2025): 19–25. https://doi.org/10.1515/medgen-2024-2065.
Texte intégralBoddicker, Nicholas J., Raphael Mwangi, Dennis P. Robinson, et al. "Abstract 5233: Germline CHEK2 variants and risk of lymphoma." Cancer Research 83, no. 7_Supplement (2023): 5233. http://dx.doi.org/10.1158/1538-7445.am2023-5233.
Texte intégralTu, J. J., L. Kuhn, L. Denny, K. J. Beattie, A. Lorincz, and T. C. Wright. "Molecular variants of human papillomavirus type 16 and risk for cervical neoplasia in South Africa." International Journal of Gynecologic Cancer 16, no. 2 (2006): 736–42. http://dx.doi.org/10.1136/ijgc-00009577-200603000-00043.
Texte intégralAment, Seth A., Szabolcs Szelinger, Gustavo Glusman, et al. "Rare variants in neuronal excitability genes influence risk for bipolar disorder." Proceedings of the National Academy of Sciences 112, no. 11 (2015): 3576–81. http://dx.doi.org/10.1073/pnas.1424958112.
Texte intégralVargas-Neri, Jessica L., Bruce Carleton, Colin J. Ross, Mara Medeiros, Gilberto Castañeda-Hernández, and Patricia Clark. "Pharmacogenomic study of anthracycline-induced cardiotoxicity in Mexican pediatric patients." Pharmacogenomics 23, no. 5 (2022): 291–301. http://dx.doi.org/10.2217/pgs-2021-0144.
Texte intégralReková, Petra, Gabriela Dostálová, David Kemlink, et al. "Detailed Phenotype of GLA Variants Identified by the Nationwide Neurological Screening of Stroke Patients in the Czech Republic." Journal of Clinical Medicine 10, no. 16 (2021): 3543. http://dx.doi.org/10.3390/jcm10163543.
Texte intégralIwaki, Hirotaka, Cornelis Blauwendraat, Hampton L. Leonard, et al. "Genetic risk of Parkinson disease and progression:." Neurology Genetics 5, no. 4 (2019): e348. http://dx.doi.org/10.1212/nxg.0000000000000348.
Texte intégralGibson, Summer B., Jonathan M. Downie, Spyridoula Tsetsou, et al. "The evolving genetic risk for sporadic ALS." Neurology 89, no. 3 (2017): 226–33. http://dx.doi.org/10.1212/wnl.0000000000004109.
Texte intégralVogan, Kyle. "Bladder exstrophy risk variants." Nature Genetics 47, no. 5 (2015): 429. http://dx.doi.org/10.1038/ng.3298.
Texte intégralDurward-Akhurst, Sian, Joy Stock, Freya Stein, Christopher Stauthammer, and Samuel Dudley. "451 Identification of candidate sudden arrhythmic death -causing variants in a spontaneous animal model." Journal of Clinical and Translational Science 8, s1 (2024): 134. http://dx.doi.org/10.1017/cts.2024.386.
Texte intégralCannon-Albright, Lisa A., Jeff Stevens, Julio C. Facelli, Craig C. Teerlink, Kristina Allen-Brady, and Neeraj Agarwal. "High-Risk Pedigree Study Identifies LRBA (rs62346982) as a Likely Predisposition Variant for Prostate Cancer." Cancers 15, no. 7 (2023): 2085. http://dx.doi.org/10.3390/cancers15072085.
Texte intégralNomura, Akihiro, Connor A. Emdin, Hong Hee Won, et al. "Heterozygous ABCG5 Gene Deficiency and Risk of Coronary Artery Disease." Circulation: Genomic and Precision Medicine 13, no. 5 (2020): 417–23. http://dx.doi.org/10.1161/circgen.119.002871.
Texte intégralOliverio, Andreina, Eleonora Bruno, Mara Colombo, et al. "BRCA1/2 Variants and Metabolic Factors: Results From a Cohort of Italian Female Carriers." Cancers 12, no. 12 (2020): 3584. http://dx.doi.org/10.3390/cancers12123584.
Texte intégralKent, Jason, and Michael C. Heinrich. "Novel models for the functional characterization of SDHA germline variants to predict cancer risk." Journal of Clinical Oncology 42, no. 16_suppl (2024): 11532. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.11532.
Texte intégralAsanomi, Yuya, Daichi Shigemizu, Shintaro Akiyama, et al. "A functional variant of SHARPIN confers increased risk of late-onset Alzheimer’s disease." Journal of Human Genetics 67, no. 4 (2021): 203–8. http://dx.doi.org/10.1038/s10038-021-00987-x.
Texte intégralWickland, Daniel P., Yingxue Ren, Jason P. Sinnwell, et al. "Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies." PLOS ONE 16, no. 4 (2021): e0249305. http://dx.doi.org/10.1371/journal.pone.0249305.
Texte intégralBobbili, Dheeraj Reddy, Peter Banda, Rejko Krüger, and Patrick May. "Excess of singleton loss-of-function variants in Parkinson’s disease contributes to genetic risk." Journal of Medical Genetics 57, no. 9 (2020): 617–23. http://dx.doi.org/10.1136/jmedgenet-2019-106316.
Texte intégralLewandowski, Laura, Linda Hiraki, Christiaan Scott, et al. "Next generation sequencing analysis reveals complex genetic architecture of childhood-onset systemic lupus erythematosus." Lupus Science & Medicine 12, no. 1 (2025): e001475. https://doi.org/10.1136/lupus-2024-001475.
Texte intégralRatajczak, Wiktoria, Angus G. Jones, Sarah D. Atkinson, and Catriona Kelly. "Type 1 Diabetes Risk Variants Reduce Beta Cell Function." Genes 16, no. 2 (2025): 172. https://doi.org/10.3390/genes16020172.
Texte intégralPramukarso, Dodik Tugasworo, Herlina Suryawati, Soetedjo Soetedjo, et al. "The Association Between Variants of Angiotensin Converting Enzyme (ACE) Gene With Risk Factors in Patients with Ischemic Stroke at Dr. Kariadi Semarang." Medica Hospitalia : Journal of Clinical Medicine 8, no. 3 (2021): 297–303. http://dx.doi.org/10.36408/mhjcm.v8i3.565.
Texte intégralKrohn, Lynne, Jennifer A. Ruskey, Uladzislau Rudakou, et al. "GBA variants in REM sleep behavior disorder." Neurology 95, no. 8 (2020): e1008-e1016. http://dx.doi.org/10.1212/wnl.0000000000010042.
Texte intégralWaller, Rosalie G., Karen Curtin, Djordje Atanackovic, Guido J. Tricot, Steven M. Lipkin, and Nicola J. Camp. "Exome Sequencing in Myeloma Pedigrees Implicates RAS1 and NOTCH Signaling Are Involved in Inherited Myeloma Risk." Blood 126, no. 23 (2015): 2976. http://dx.doi.org/10.1182/blood.v126.23.2976.2976.
Texte intégralAcharya, Ratna, and Kiran Upadhyay. "Early recurrence of focal segmental glomerulosclerosis in a kidney transplant recipient withAPOL1one risk variant." BMJ Case Reports 16, no. 5 (2023): e254593. http://dx.doi.org/10.1136/bcr-2023-254593.
Texte intégralKarantanos, Theodoros, Shruti Chaturvedi, Christopher D. Gocke, Donna Marie Williams, Alison R. Moliterno, and Evan M. Braunstein. "ATM Germline Variant Increases the Risk of MPN Progression." Blood 134, Supplement_1 (2019): 835. http://dx.doi.org/10.1182/blood-2019-125362.
Texte intégralLi, Qingqin S., Chao Tian, David Hinds, and Guy R. Seabrook. "The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship." PLOS ONE 15, no. 11 (2020): e0241552. http://dx.doi.org/10.1371/journal.pone.0241552.
Texte intégralArning, Astrid, Astrid Jeibmann, Stephan Köhnemann, et al. "ADAMTS genes and the risk of cerebral aneurysm." Journal of Neurosurgery 125, no. 2 (2016): 269–74. http://dx.doi.org/10.3171/2015.7.jns154.
Texte intégralVeyrat-Durebex, Charlotte, Nathalie Bouzamondo, Morgane Le Mao, et al. "Metabolomics signatures of a subset of RET variants according to their oncogenic risk level." Endocrine-Related Cancer 26, no. 3 (2019): 379–89. http://dx.doi.org/10.1530/erc-18-0314.
Texte intégralNguyen-Dumont, Tú, James G. Dowty, Jason A. Steen, et al. "Population-Based Estimates of the Age-Specific Cumulative Risk of Breast Cancer for Pathogenic Variants in CHEK2: Findings from the Australian Breast Cancer Family Registry." Cancers 13, no. 6 (2021): 1378. http://dx.doi.org/10.3390/cancers13061378.
Texte intégralFoley, Georgea R., James R. Marthick, Sionne E. Lucas, et al. "Germline Sequencing of DNA Damage Repair Genes in Two Hereditary Prostate Cancer Cohorts Reveals New Disease Risk-Associated Gene Variants." Cancers 16, no. 13 (2024): 2482. http://dx.doi.org/10.3390/cancers16132482.
Texte intégralNurmi, Anna K., Maija Suvanto, Joe Dennis, Kristiina Aittomäki, Carl Blomqvist, and Heli Nevanlinna. "Pathogenic Variant Spectrum in Breast Cancer Risk Genes in Finnish Patients." Cancers 14, no. 24 (2022): 6158. http://dx.doi.org/10.3390/cancers14246158.
Texte intégralOlabisi, Opeyemi A., Jia-Yue Zhang, Lynn VerPlank, et al. "APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases." Proceedings of the National Academy of Sciences 113, no. 4 (2015): 830–37. http://dx.doi.org/10.1073/pnas.1522913113.
Texte intégralSoufir, N., L. Bagait Miss, C. Oudin Miss, et al. "MC1R variants and melanoma risk: First study on Melan-Cohort." Journal of Clinical Oncology 25, no. 18_suppl (2007): 10524. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.10524.
Texte intégralHawkins, Gregory A., David J. Friedman, Lingyi Lu, et al. "Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression." American Journal of Nephrology 42, no. 2 (2015): 99–106. http://dx.doi.org/10.1159/000439448.
Texte intégralReilly, Christopher R., Mikko Myllymäki, Robert Redd, et al. "The clinical and functional effects of TERT variants in myelodysplastic syndrome." Blood 138, no. 10 (2021): 898–911. http://dx.doi.org/10.1182/blood.2021011075.
Texte intégralZenteno, Juan C., Oscar F. Chacón-Camacho, Vianey Ordoñez-Labastida, et al. "Identification of Genetic Variants for Diabetic Retinopathy Risk Applying Exome Sequencing in Extreme Phenotypes." BioMed Research International 2024 (January 13, 2024): 1–8. http://dx.doi.org/10.1155/2024/2052766.
Texte intégralZavaleta, Elizabeth, Nelly Solis, Maria Isabel Palacios, et al. "Genetic Characterization in High-Risk Individuals from a Low-Resource City of Peru." Cancers 14, no. 22 (2022): 5603. http://dx.doi.org/10.3390/cancers14225603.
Texte intégralBryant, Nicole, Nicole Malpeli, Julia Ziaee, Cornelis Blauwendraat, Zhiyong Liu, and Andrew B. West. "Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson’s disease cohort." Human Molecular Genetics 30, no. 6 (2021): 454–66. http://dx.doi.org/10.1093/hmg/ddab058.
Texte intégralHostetler, Ellen M., Ellen S. Regalado, Dong-Chuan Guo, et al. "SMAD3 pathogenic variants: risk for thoracic aortic disease and associated complications from the Montalcino Aortic Consortium." Journal of Medical Genetics 56, no. 4 (2019): 252–60. http://dx.doi.org/10.1136/jmedgenet-2018-105583.
Texte intégralTrottier, Amy M., Lawrence J. Druhan, Ira L. Kraft, et al. "Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies." Blood Advances 4, no. 20 (2020): 5269–84. http://dx.doi.org/10.1182/bloodadvances.2020002013.
Texte intégralAI-Ghalayini, Kamal W., Mohammed A. Salama, Hadia Bassam Al Mahdi, et al. "Identification of Genetic Variants Associated With Myocardial Infarction in Saudi Arabia." Heart Surgery Forum 23, no. 4 (2020): E517—E523. http://dx.doi.org/10.1532/hsf.2955.
Texte intégralReiner, Anne S., Mark E. Robson, Lene Mellemkjær, et al. "Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer." JNCI: Journal of the National Cancer Institute 112, no. 12 (2020): 1275–79. http://dx.doi.org/10.1093/jnci/djaa031.
Texte intégralZhou, Xiaopu, Yu Chen, Kin Y. Mok, et al. "Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis." Proceedings of the National Academy of Sciences 115, no. 8 (2018): 1697–706. http://dx.doi.org/10.1073/pnas.1715554115.
Texte intégralDinur, Tama, Michal Becker-Cohen, Shoshana Revel-Vilk, Ari Zimran, and David Arkadir. "Parkinson’s Clustering in Families of Non-Neuronopathic N370S GBA Mutation Carriers Indicates the Presence of Genetic Modifiers." Journal of Parkinson's Disease 11, no. 2 (2021): 615–18. http://dx.doi.org/10.3233/jpd-202422.
Texte intégral